{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:44:47Z","timestamp":1791902687098,"version":"4.3.4"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,24]]},"abstract":"<jats:p>The introduction of Janus kinase inhibitors has revolutionized the management of alopecia areata. We conducted a monocentric retrospective study to compare the clinical, trichoscopic and safety outcomes of baricitinib, ritlecitinib and upadacitinib in patients with moderate to severe alopecia areata.<\/jats:p>","DOI":"10.1093\/ced\/llaf509","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T12:55:48Z","timestamp":1763470548000},"page":"491-493","source":"Crossref","is-referenced-by-count":5,"title":["Comparative clinical, trichoscopic and safety outcomes of baricitinib, ritlecitinib and upadacitinib in alopecia areata: a real-world experience"],"prefix":"10.1093","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6646-9864","authenticated-orcid":false,"given":"Luciano","family":"Foggia","sequence":"first","affiliation":[{"name":"Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Nappa","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia Sof\u00eda","family":"Ocampo-Garza","sequence":"additional","affiliation":[{"name":"Dermatology Department, Dr. Jos\u00e9 Eleuterio Gonz\u00e1lez University Hospital, Autonomous University of Nuevo Le\u00f3n , Monterrey, Nuevo Le\u00f3n ,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carmela","family":"Annunziata","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariateresa","family":"Cantelli","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cataldo","family":"Patruno","sequence":"additional","affiliation":[{"name":"Vincenzo Tiberio Department of Medicine and Health Sciences, University of Molise , Campobasso ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5940-0592","authenticated-orcid":false,"given":"Luca","family":"Potestio","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Napolitano","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"issue":"2 Suppl","key":"2026022406164905100_llaf509-B1","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.jaad.2023.05.049","article-title":"Janus kinase inhibitors for alopecia areata","volume":"89","author":"King","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"2026022406164905100_llaf509-B2","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s40265-023-01873-w","article-title":"Baricitinib for the treatment of alopecia areata","volume":"83","author":"Freitas","year":"2023","journal-title":"Drugs"},{"key":"2026022406164905100_llaf509-B3","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S0140-6736(23)00222-2","article-title":"Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial","volume":"401","author":"King","year":"2023","journal-title":"Lancet"},{"key":"2026022406164905100_llaf509-B4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/13543784.2024.2348062","article-title":"Novel investigational drugs for alopecia areata and future perspectives","volume":"33","author":"Chim","year":"2024","journal-title":"Expert Opin Investig Drugs"},{"key":"2026022406164905100_llaf509-B5","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1007\/s13555-025-01468-1","article-title":"Therapeutic burden as predictor of response to baricitinib for alopecia areata in real life: prospective study","volume":"15","author":"Mu\u00f1oz-Barba","year":"2025","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2026022406164905100_llaf509-B6","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1080\/14740338.2024.2348571","article-title":"Infectious events in patients with alopecia areata treated with JAK inhibitors: low burden and minimal impact on persistence in treatment","volume":"23","author":"Caldarola","year":"2024","journal-title":"Expert Opin Drug Saf"},{"key":"2026022406164905100_llaf509-B7","doi-asserted-by":"crossref","first-page":"2268764","DOI":"10.1080\/09546634.2023.2268764","article-title":"Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience","volume":"34","author":"Gargiulo","year":"2023","journal-title":"J Dermatolog Treat"},{"key":"2026022406164905100_llaf509-B8","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1093\/ced\/llaf312","article-title":"Real-world assessment of ritlecitinib in patients with severe alopecia areata: a 24-week multicenter retrospective study","volume":"50","author":"Valtellini","year":"2025","journal-title":"Clin Exp Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llaf509\/65378250\/llaf509.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llaf509\/65378250\/llaf509.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llaf509\/65378250\/llaf509.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T11:16:55Z","timestamp":1771931815000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/51\/3\/491\/8327159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":8,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,11,19]]},"published-print":{"date-parts":[[2026,2,24]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llaf509","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,11,19]]}}}